Convergent Ventures

About The Fund

Convergent Ventures is an investment fund focused on seed-stage venture capital investments, particularly in the life sciences sector. They have a strong emphasis on therapeutic pharmaceuticals and biotechnology products. As part of their operations, Convergent Ventures has established a group of companies that include Convergent Ventures, LLC—a private holding company with interests in new therapeutics and enabling technologies for drug research and development; Convergent Management, Inc.—a management and strategy consulting firm; and Convergent Cycling & Performance Products—a marketing and sales management company. They have created Convergent Investors, LLC, a seed-stage venture capital fund that is now fully invested. With a specific interest in early-stage companies, they commit to a uniform investment size, with both their minimum and maximum investment amount being $1,500,000. This reflects their targeted approach to financing and supporting startups during pivotal stages of their development. Convergent Ventures takes a hands-on approach to venture management, leveraging their expertise and resources across their group of companies to support the portfolio companies in their growth and development. Despite this detailed information about their investment strategy and company structure, it appears that the primary domain of Convergent Ventures (convergentventures.com) is currently listed for sale, which raises questions about the current status of the firm and its operations.